study | Publication year | Sample collection date | country | continent | Study-design | Sample type | Detection target | Case | Case positive | Control | Control positive | Detection method | Age control | Age case | NOS score | ref |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Giovanna | 2013 | Since 2006 | Colombia | South America | Case–control | FFPE | Gag | 53 | 19 | 53 | 24 | PCR | 52.2 | 46.4 | 8 | [14] |
Schwingel | 2019 | 2015–2017 | Brazil | South America | Case–control | FFPE | Tax | 72 | 22 | 72 | 10 | Nested PCR | 38 | 52.5 | 9 | [15] |
Buehring | 2007 | NR | US | North America | Case–control | FFPE | Tax | 110 | 65 | 103 | 30 | In situ PCR | NR | NR | 9 | [16] |
Buehring | 2015 | 2002–2008 | US | North America | Case–control | FFPE | Tax | 114 | 67 | 104 | 30 | In situ PCR | 48.7 | 55.9 | 9 | [17] |
Baltzell | 2017 | 2009–2011 | US | North America | Case–control | FFPE | Tax | 61 | 35 | 103 | 20 | In situ PCR | 54.4 | 54.59 | 9 | [18] |
Buehring | 2017 | 1995–2010 | Australia | ocenia | Case–control | FFPE | Tax | 50 | 40 | 46 | 19 | In situ PCR | 49.59 | 55.08 | 9 | [12] |
Lawson and Glenn | 2017 | NR | Australia | ocenia | Case–control | FFPE | Tax | 22 | 20 | 17 | 6 | In situ PCR | 36.4 | 56.1 | 8 | [19] |
Khalilian | 2019 | 2017–2018 | Iran | Middle East | Case–control | FFPE and Blood | Tax | 172 | 52 | 200 | 60 | In situ PCR | 47.5 | 53 | 9 | [11] |
Khalilian | 2019 | 2017–2018 | Iran | Middle east | Case–control | FFPE and Blood | Gag | 172 | 14 | 200 | 16 | Nested PCR | 47.5 | 53 | 8 | [11] |